Skip to main content

ABL HIV and HCV Genotyping and Sequencing Assays

Advanced Biological Laboratories has launched DeepChek SingleRound HIV and Hepatitis C virus genotyping and sequencing assays. These two assays are the first in the ABL's virology reagents portfolio and are currently available for research use only, the company said in a statement.

The DeepChek SingleRound HIV RT-PCR and sequencing assay detects all major HIV-1 subtypes (i.e. B, C, F, A1, D, 02_AG, etc.). The assay combines all the reagents and protocols required to perform the amplification and sequencing of reverse transcriptase, protease, and integrase. The overall performance in sensitivity and susceptibility is comparable to available commercial kits and the amplification step was successful in samples with low viral load down to 300 copies/mL, the company stated. The DeepChek SingleRound HCV genotyping and subtyping assay detects genotypes 1, 2, 3, 4, 5, and 6— more specifically subtypes 1a and 1b — by targeting NS5B and 5'UTR HCV coding regions. It exhibits a limit of detection of 1000 IU/mL. Both assays are bundled with ViroScore and DeepChek software, and both are CE-marked for IVD use with Sanger and next-generation sequencing, respectively. 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.